William Meury
CIK 1536778 · Chief Executive Officer · last filed 2026-04-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$19.13M
Companies
7
Total Filings
52
Lifetime Open-Market Net
-$19.27M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| INCY | Chief Executive Officer | 161,101 | $108.53 | $17.48M | $0 | 3 | 2026-04-17 |
| SNDX | Director | 90,000 | $18.25 | $1.64M | -$1.70M | 9 | 2025-02-07 |
| Karuna Therapeutics, Inc. (KRTX) Delisted | President and CEO | 19,037 | $329.83 | $6.28M | $0 | 4 | 2024-03-18 |
| Allergan plc (AGN) Delisted | EVP & Chief Commercial Officer | 0 | — | — | -$3.78M | 8 | 2020-05-11 |
| Allergan plc (AGNpA) Delisted | Chief Commercial Officer | 42,521 | — | — | -$11.51M | 10 | 2018-02-16 |
| Allergan plc (ACTpA) Delisted | See Remarks | 71,194 | — | — | $0 | 2 | 2015-05-19 |
| Forest Laboratories, LLC (FRX) Delisted | EVP - Sales and Marketing | 87,542 | $12.00 | $1.05M | -$2.28M | 11 | 2013-12-10 |
Recent Filings · Page 3 of 6
52 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-01-03 | Allergan plc (AGN) Delisted | Tax (F) | −1,531 | -$204.6K | EDGAR |
| 2018-09-27 | SNDX | Grant (A) | — | $0 | EDGAR |
| 2018-05-21 | Allergan plc (AGN) Delisted | Mixed | −3,173 | -$2.33M | EDGAR |
| 2018-04-05 | Allergan plc (AGN) Delisted | Tax (F) | −819 | -$134.9K | EDGAR |
| 2018-02-16 | Allergan plc (AGNpA) Delisted | Mixed | −35,266 | -$7.97M | EDGAR |
| 2018-01-02 | Allergan plc (AGNpA) Delisted | Tax (F) | −1,611 | -$263.5K | EDGAR |
| 2017-12-04 | Allergan plc (AGNpA) Delisted | Mixed | — | -$1.12M | EDGAR |
| 2017-10-30 | Allergan plc (AGNpA) Delisted | Exer (M) | +9,321 | $0 | EDGAR |
| 2017-05-16 | Allergan plc (AGNpA) Delisted | Tax (F) | −587 | -$134.0K | EDGAR |
| 2017-04-04 | Allergan plc (AGNpA) Delisted | Grant (A) | +8,835 | $2.10M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.